EZH2 variants derived from cryptic splice sites govern distinct epigenetic patterns during embryonic development
Nucleic Acids Research · 05.09.2025 · 53 (17)
DOI: 10.1093/nar/gkaf869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 09.09.2025. Verfasst von Ningning Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences, Shenzhen 518057, China. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Embryonic Development, Epigenesis, Genetic, RNA Splice Sites. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shenzhen Medical Research Fund, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
EZH2 catalyzes H3K27me3 and is essential for embryonic development. Although multiple EZH2 variants have been identified, the functional implications and physiological significance of its heterogeneity remain unclear. Here, we revealed that conserved cryptic splice sites generated two EZH2 variants with (EZH2A) or without (EZH2B) a 27-nt region, coding for a 9-aa segment. Structural modeling showed that splice-in or splice-off of the 9-aa segment caused a topological change in EZH2 structure. The 9-aa surplus in EZH2A strengthened its interaction with other PRC2 components, particularly in PRC2.2 holocomplex. We developed point-mutation mouse lines specifically depleting EZH2A or EZH2B (Ezh2amut or Ezh2bmut). Biallelic deletion of Ezh2a caused developmental defects and embryonic lethality between E12.5 and E15.5, while the Ezh2bmut mice were fertile and developed normally. Combined RNA-seq and CUT&Tag analyses in mouse embryonic fibroblasts revealed that EZH2A and EZH2B bound to different genomic loci and affected H3K27me3 deposition in different subsets of genes related to development or the innate immune system, respectively. EZH2A depletion specifically suppressed the expression of genes involved in the development-related Hippo-Yap1 pathway, which might be attributable to a compensatory process mediated by JARID2. Our findings demonstrate that EZH2 heterogeneity from the 9-aa splicing event plays a crucial role in development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences, Shenzhen 518057, China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
ORCID-Profile: Zhihua Wang
Förderung
- Shenzhen Medical Research Fund
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Commission
- Chinese Academy of Medical Sciences Innovation Fund
- National High Level Hospital Clinical Research
Zitieren
APA
Guo, N., Guo, Q., Zhan, H., Lv, J., Fang, Y., Li, J., Wang, J., Li, D., Ma, X., Yan, Q., & Wang, Z. (2025). EZH2 variants derived from cryptic splice sites govern distinct epigenetic patterns during embryonic development. Nucleic Acids Research, 53(17). https://doi.org/10.1093/nar/gkaf869
Vancouver
Guo N, Guo Q, Zhan H, Lv J, Fang Y, Li J, et al. EZH2 variants derived from cryptic splice sites govern distinct epigenetic patterns during embryonic development. Nucleic Acids Research. 2025;53(17). doi:10.1093/nar/gkaf869
BibTeX
@article{Guo2025,
author = {Guo, Ningning and Guo, Qiuxiao and Zhan, Hongchao and Lv, Jian and Fang, Yu and Li, Jiajie and Wang, Junmei and Li, Die and Ma, Xiao and Yan, Qingqing and Wang, Zhihua},
title = {EZH2 variants derived from cryptic splice sites govern distinct epigenetic patterns during embryonic development},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {17},
doi = {10.1093/nar/gkaf869}
}
EUVIMED